The use of incretins and fractures - a meta-analysis on population-based real life data

Johanna H. M. Driessen; Frank de Vries; Hein van Onzenoort; Nicholas C. Harvey; Cees Neef; Joop P. W. van den Bergh; Peter Vestergaard; Ronald M. A. Henry

doi:10.1111/bcp.13167

The use of incretins and fractures - a meta-analysis on population-based real life data

Johanna H. M. Driessen, Frank de Vries^*, Hein van Onzenoort, Nicholas C. Harvey, Cees Neef, Joop P. W. van den Bergh, Peter Vestergaard, Ronald M. A. Henry

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	923-926
Number of pages	4
Journal	British Journal of Clinical Pharmacology
Volume	83
Issue number	4
DOIs	https://doi.org/10.1111/bcp.13167
Publication status	Published - Apr 2017

Keywords

dipeptidyl peptidase 4-inhibitors
fracture
glucagon-like peptide 1-receptor agonists
incretin agents
meta-analysis
PEPTIDE-1 RECEPTOR AGONISTS
DIPEPTIDYL PEPTIDASE-4 INHIBITORS
RANDOMIZED CLINICAL-TRIALS
ANTI-HYPERGLYCEMIC DRUGS
BONE-FRACTURES
RISK

Access to Document

10.1111/bcp.13167

Cite this

Driessen, J. H. M., de Vries, F., van Onzenoort, H., Harvey, N. C., Neef, C., van den Bergh, J. P. W., Vestergaard, P., & Henry, R. M. A. (2017). The use of incretins and fractures - a meta-analysis on population-based real life data. British Journal of Clinical Pharmacology, 83(4), 923-926. https://doi.org/10.1111/bcp.13167

@article{3ac999f93ac24e67aa65f760c6caa8d8,

title = "The use of incretins and fractures - a meta-analysis on population-based real life data",

keywords = "dipeptidyl peptidase 4-inhibitors, fracture, glucagon-like peptide 1-receptor agonists, incretin agents, meta-analysis, PEPTIDE-1 RECEPTOR AGONISTS, DIPEPTIDYL PEPTIDASE-4 INHIBITORS, RANDOMIZED CLINICAL-TRIALS, ANTI-HYPERGLYCEMIC DRUGS, BONE-FRACTURES, RISK",

author = "Driessen, {Johanna H. M.} and {de Vries}, Frank and {van Onzenoort}, Hein and Harvey, {Nicholas C.} and Cees Neef and {van den Bergh}, {Joop P. W.} and Peter Vestergaard and Henry, {Ronald M. A.}",

year = "2017",

month = apr,

doi = "10.1111/bcp.13167",

language = "English",

volume = "83",

pages = "923--926",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley",

number = "4",

}

The use of incretins and fractures - a meta-analysis on population-based real life data. / Driessen, Johanna H. M.; de Vries, Frank; van Onzenoort, Hein; Harvey, Nicholas C.; Neef, Cees ; van den Bergh, Joop P. W.; Vestergaard, Peter; Henry, Ronald M. A.

In: British Journal of Clinical Pharmacology, Vol. 83, No. 4, 04.2017, p. 923-926.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The use of incretins and fractures - a meta-analysis on population-based real life data

AU - Driessen, Johanna H. M.

AU - de Vries, Frank

AU - van Onzenoort, Hein

AU - Harvey, Nicholas C.

AU - Neef, Cees

AU - van den Bergh, Joop P. W.

AU - Vestergaard, Peter

AU - Henry, Ronald M. A.

PY - 2017/4

Y1 - 2017/4

KW - dipeptidyl peptidase 4-inhibitors

KW - fracture

KW - glucagon-like peptide 1-receptor agonists

KW - incretin agents

KW - meta-analysis

KW - PEPTIDE-1 RECEPTOR AGONISTS

KW - DIPEPTIDYL PEPTIDASE-4 INHIBITORS

KW - RANDOMIZED CLINICAL-TRIALS

KW - ANTI-HYPERGLYCEMIC DRUGS

KW - BONE-FRACTURES

KW - RISK

U2 - 10.1111/bcp.13167

DO - 10.1111/bcp.13167

M3 - Article

VL - 83

SP - 923

EP - 926

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 4

ER -